株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

放射性医薬品の世界市場

Radiopharmaceuticals

発行 Global Industry Analysts, Inc. 商品コード 225236
出版日 ページ情報 英文 400 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

放射性医薬品の世界市場 Radiopharmaceuticals
出版日: 2020年05月01日 ページ情報: 英文 400 Pages
概要

当レポートでは、世界の放射性医薬品市場について調査し、市場の概要と競合動向、製品概要、地域別の動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • 序論
    • 現在および将来分析
    • 診断用放射性医薬品:独占的セグメント
    • 心臓・腫瘍のための放射性医薬品
    • 新たな治療用放射性医薬品が世界市場を牽引
    • 市場促進因子
      • 癌治療における受容性拡大
      • 疾患標的治療の受容性拡大
      • 正確な診断の強調
      • 分子画像への応用
    • 市場阻害因子
      • 厳しい法規制ガイドライン
      • 世界の供給不足
      • 価格感受性と競合
    • 途上国の動向 他
  • 長期的成長牽引因子
    • 癌発症率上昇
    • 年齢による癌に罹患しやすい部位
    • 高齢化
    • 世界の心血管疾患統計
  • 製品概要
    • 放射性医薬品:定義
    • 作用機序
    • 放射性医薬品の応用
    • 画像診断のための放射性トレーサー
    • 治療法
    • 研究
    • 滅菌
    • 放射性医薬品の分類
    • 診断用放射性医薬品
    • 治療用放射性医薬品
  • 製品技術革新/導入
  • 近年の業界活動
  • 主要企業
    • Actinium Pharmaceuticals, Inc.
    • Alliance Medical
    • Alseres Pharmaceuticals, Inc.
    • Avid Radiopharmaceuticals
    • Bayer HealthCare Pharmaceuticals
    • Bracco Diagnostics, Inc.
    • Cardinal Health, Inc.
    • GE Healthcare
    • Ion Beam Applications S.A
    • Immunomedics, Inc.
    • Jubilant Pharma
    • Lantheus Medical Imaging Inc.
    • Medi-Radiopharma Ltd
    • Nordion, Inc.
    • Peregrine Pharmaceuticals, Inc.
    • PETNET Solutions Inc.
    • Positron Corporation
    • Triad Isotopes, Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ
目次
Product Code: MCP-1889

Amid the COVID-19 crisis and the looming economic recession, the Radiopharmaceuticals market worldwide will grow by a projected US$3.8 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 7.3%. SPECT Radioisotopes, one of the segments analyzed and sized in this study, is forecast to grow at over 7.3% and reach a market size of US$4.3 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The SPECT Radioisotopes market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 5.8% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$113.2 Million to the region's size over the next 7 to 8 years. In addition, over US$109.4 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the SPECT Radioisotopes segment will reach a market size of US$184.5 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Radiopharmaceuticals market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 11.7% over the next couple of years and add approximately US$964.4 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Radiopharmaceuticals market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Actinium Pharmaceuticals Inc.; Alliance Medical; Alseres Pharmaceuticals Inc.; Avid Radiopharmaceuticals; Bayer HealthCare, Radiology Division; Bracco Diagnostics Inc.; Cardinal Health, Inc.; GE Healthcare; Immunomedics, Inc.; Ion Beam Applications SA; Jubilant Pharma; Lantheus Medical Imaging Inc.; Medi-Radiopharma Ltd.; Nordion, Inc.; Peregrine Pharmaceuticals, Inc.; PETNET Solutions Inc.; Positron Corporation; Triad Isotopes Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession
  • A Prelude
  • Recent Market Activity
  • Current & Future Analysis
  • Diagnostic Radiopharmaceuticals: The Dominant Segment
  • Select Cardiology and Oncology Radiopharmaceuticals
  • New Therapeutic Radiopharmaceuticals to Drive Global Market
  • Competition
  • Relevant Aspects of Radiopharmaceutical Production
  • Intra-operative Lymphatic Mapping (ILM): Creates New Opportunities for Radiopharmaceuticals in Cancer Detection
  • Global Competitor Market Shares
  • Radiopharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

  • Actinium Pharmaceuticals, Inc. (USA)
  • Alliance Medical (UK)
  • Alseres Pharmaceuticals, Inc. (USA)
  • Avid Radiopharmaceuticals (USA)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Bracco Diagnostics, Inc. (USA)
  • Cardinal Health, Inc. (USA)
  • GE Healthcare (UK)
  • Ion Beam Applications S.A (Belgium)
  • Immunomedics, Inc. (USA)
  • Jubilant Pharma (India)
  • Lantheus Medical Imaging Inc. (USA)
  • Medi-Radiopharma Ltd (Hungary)
  • Nordion, Inc. (Canada)
  • Peregrine Pharmaceuticals, Inc. (USA)
  • PETNET Solutions Inc. (USA)
  • Positron Corporation (USA)
  • Triad Isotopes, Inc. (USA)

3. MARKET TRENDS & DRIVERS

  • Rise in Incidence of Cancer - A Major Growth Driver
  • Cancer Prone Sites based on Age
  • Ageing Population - A Vital Demography
  • Global CVD Stats
  • Market Drivers
  • Growing Acceptance in Cancer Treatment
  • Increasing Acceptance of Disease-Targeted Treatment
  • Growing Emphasis of Accurate Diagnosis
  • Expanding Molecular Imaging Applications
  • Market Restraints
  • Stringent Regulatory Guidelines for Manufacture, Storage and Usage
  • Global Supply Shortages
  • Price Sensitivity & Competition from Alternatives
  • Lack of Dosage Standards for Pediatric Patients Limits Radiopharmaceutical Efficacy
  • Unfounded Fears of Radiation Exposure Hinder Growth
  • Bottlenecks in Developing Markets
  • Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance
  • Increasing Uptake of PET: A Prime Growth Driver
  • Non-Reactor Based TC-99m Production to Drive SPECT Growth
  • New Radiopharmaceuticals Drive Adoption of Molecular Imaging
  • PET and SPECT in Cardiovascular Imaging
  • Innovative Radiotracers - Key to PET & SPECT Success in Cardiovascular Imaging
  • Cardiac Amyloidosis Visualization - A Potential Application for PET
  • Application of PET in Drug Development to Expand Opportunities
  • Industry Focus Gears up for innovative Radiopharmaceuticals with Therapeutic Benefits
  • Innovative Radiopharmaceuticals to Boost Cardiac Applications
  • Personalized Medicine to Drive Nuclear Medicine
  • Rise in Incidence of Neurological Disorders to Drive Growth
  • Battling Alzheimer's Disease - A Powerful Market Force for Nuclear Medicine
  • Combating the Shortage of RadioIsotopes

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Radiopharmaceuticals Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Radiopharmaceuticals Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Radiopharmaceuticals Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: SPECT Radioisotopes (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: SPECT Radioisotopes (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: SPECT Radioisotopes (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: PET Radioisotopes (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: PET Radioisotopes (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: PET Radioisotopes (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Beta Emitters (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Beta Emitters (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Beta Emitters (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Alpha Emitters (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Alpha Emitters (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Alpha Emitters (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Other Product Types (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: Other Product Types (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: Other Product Types (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Oncology (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 20: Oncology (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 21: Oncology (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Cardiology (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Cardiology (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Cardiology (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Neurology (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 26: Neurology (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 27: Neurology (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
  • TABLE 28: Other Applications (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 29: Other Applications (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 30: Other Applications (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 31: Hospitals & Diagnostic Centers (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
  • TABLE 32: Hospitals & Diagnostic Centers (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 33: Hospitals & Diagnostic Centers (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 34: Research Institutes (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 35: Research Institutes (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 36: Research Institutes (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Radiopharmaceuticals Market Share (in %) by Company: 2020 & 2025
    • Market Analytics
    • TABLE 37: United States Radiopharmaceuticals Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 38: Radiopharmaceuticals Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 39: United States Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 40: United States Radiopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 41: Radiopharmaceuticals Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
    • TABLE 42: Radiopharmaceuticals Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
    • TABLE 43: United States Radiopharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 44: Radiopharmaceuticals Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
    • TABLE 45: Radiopharmaceuticals Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 46: Canadian Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 47: Canadian Radiopharmaceuticals Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 48: Radiopharmaceuticals Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
    • TABLE 49: Canadian Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 50: Radiopharmaceuticals Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 51: Canadian Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 52: Canadian Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 53: Radiopharmaceuticals Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 54: Canadian Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 55: Japanese Market for Radiopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 56: Radiopharmaceuticals Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 57: Japanese Radiopharmaceuticals Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 58: Japanese Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 59: Japanese Radiopharmaceuticals Market in US$ Million by Application: 2012-2019
    • TABLE 60: Radiopharmaceuticals Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
    • TABLE 61: Japanese Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 62: Japanese Radiopharmaceuticals Market in US$ Million by End-Use: 2012-2019
    • TABLE 63: Radiopharmaceuticals Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 64: Chinese Radiopharmaceuticals Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 65: Radiopharmaceuticals Historic Market Analysis in China in US$ Million by Product Type: 2012-2019
    • TABLE 66: Chinese Radiopharmaceuticals Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 67: Chinese Demand for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 68: Radiopharmaceuticals Market Review in China in US$ Million by Application: 2012-2019
    • TABLE 69: Chinese Radiopharmaceuticals Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 70: Chinese Demand for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 71: Radiopharmaceuticals Market Review in China in US$ Million by End-Use: 2012-2019
    • TABLE 72: Chinese Radiopharmaceuticals Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Radiopharmaceuticals Market: Competitor Market Share Scenario (in %) for 2020 & 2025
    • Market Analytics
    • TABLE 73: European Radiopharmaceuticals Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 74: Radiopharmaceuticals Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 75: European Radiopharmaceuticals Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 76: European Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 77: Radiopharmaceuticals Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 78: European Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 79: European Radiopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 80: Radiopharmaceuticals Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 81: European Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 82: European Radiopharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 83: Radiopharmaceuticals Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 84: European Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 85: Radiopharmaceuticals Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 86: French Radiopharmaceuticals Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 87: French Radiopharmaceuticals Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 88: Radiopharmaceuticals Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
    • TABLE 89: French Radiopharmaceuticals Historic Market Review in US$ Million by Application: 2012-2019
    • TABLE 90: French Radiopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 91: Radiopharmaceuticals Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
    • TABLE 92: French Radiopharmaceuticals Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 93: French Radiopharmaceuticals Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 94: Radiopharmaceuticals Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 95: German Radiopharmaceuticals Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 96: German Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 97: Radiopharmaceuticals Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 98: German Radiopharmaceuticals Market in Retrospect in US$ Million by Application: 2012-2019
    • TABLE 99: Radiopharmaceuticals Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
    • TABLE 100: Radiopharmaceuticals Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 101: German Radiopharmaceuticals Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 102: Radiopharmaceuticals Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 103: Italian Radiopharmaceuticals Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 104: Radiopharmaceuticals Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019
    • TABLE 105: Italian Radiopharmaceuticals Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 106: Italian Demand for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 107: Radiopharmaceuticals Market Review in Italy in US$ Million by Application: 2012-2019
    • TABLE 108: Italian Radiopharmaceuticals Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 109: Italian Demand for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 110: Radiopharmaceuticals Market Review in Italy in US$ Million by End-Use: 2012-2019
    • TABLE 111: Italian Radiopharmaceuticals Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 112: United Kingdom Market for Radiopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 113: Radiopharmaceuticals Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 114: United Kingdom Radiopharmaceuticals Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 115: United Kingdom Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 116: United Kingdom Radiopharmaceuticals Market in US$ Million by Application: 2012-2019
    • TABLE 117: Radiopharmaceuticals Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
    • TABLE 118: United Kingdom Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 119: United Kingdom Radiopharmaceuticals Market in US$ Million by End-Use: 2012-2019
    • TABLE 120: Radiopharmaceuticals Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 121: Spanish Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 122: Spanish Radiopharmaceuticals Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 123: Radiopharmaceuticals Market in Spain: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
    • TABLE 124: Spanish Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 125: Radiopharmaceuticals Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 126: Spanish Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 127: Spanish Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 128: Radiopharmaceuticals Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 129: Spanish Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • RUSSIA
    • TABLE 130: Russian Radiopharmaceuticals Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 131: Radiopharmaceuticals Market in Russia by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 132: Russian Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 133: Russian Radiopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 134: Radiopharmaceuticals Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019
    • TABLE 135: Radiopharmaceuticals Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027
    • TABLE 136: Russian Radiopharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 137: Radiopharmaceuticals Historic Demand Patterns in Russia by End-Use in US$ Million for 2012-2019
    • TABLE 138: Radiopharmaceuticals Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 139: Rest of Europe Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 140: Radiopharmaceuticals Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 141: Rest of Europe Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 142: Rest of Europe Radiopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 143: Radiopharmaceuticals Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 144: Rest of Europe Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 145: Rest of Europe Radiopharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 146: Radiopharmaceuticals Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 147: Rest of Europe Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 148: Asia-Pacific Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 149: Radiopharmaceuticals Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 150: Asia-Pacific Radiopharmaceuticals Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 151: Radiopharmaceuticals Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 152: Asia-Pacific Radiopharmaceuticals Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 153: Asia-Pacific Radiopharmaceuticals Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 154: Radiopharmaceuticals Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
    • TABLE 155: Asia-Pacific Radiopharmaceuticals Historic Market Review in US$ Million by Application: 2012-2019
    • TABLE 156: Asia-Pacific Radiopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 157: Radiopharmaceuticals Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
    • TABLE 158: Asia-Pacific Radiopharmaceuticals Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 159: Asia-Pacific Radiopharmaceuticals Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • AUSTRALIA
    • TABLE 160: Radiopharmaceuticals Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 161: Australian Radiopharmaceuticals Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 162: Australian Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 163: Radiopharmaceuticals Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 164: Australian Radiopharmaceuticals Market in Retrospect in US$ Million by Application: 2012-2019
    • TABLE 165: Radiopharmaceuticals Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027
    • TABLE 166: Radiopharmaceuticals Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 167: Australian Radiopharmaceuticals Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 168: Radiopharmaceuticals Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 169: Indian Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 170: Indian Radiopharmaceuticals Historic Market Review by Product Type in US$ Million: 2012-2019
    • TABLE 171: Radiopharmaceuticals Market in India: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
    • TABLE 172: Indian Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 173: Radiopharmaceuticals Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 174: Indian Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 175: Indian Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 176: Radiopharmaceuticals Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 177: Indian Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • SOUTH KOREA
    • TABLE 178: Radiopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 179: South Korean Radiopharmaceuticals Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 180: Radiopharmaceuticals Market Share Distribution in South Korea by Product Type: 2012 VS 2020 VS 2027
    • TABLE 181: Radiopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
    • TABLE 182: South Korean Radiopharmaceuticals Historic Market Analysis in US$ Million by Application: 2012-2019
    • TABLE 183: Radiopharmaceuticals Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027
    • TABLE 184: Radiopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
    • TABLE 185: South Korean Radiopharmaceuticals Historic Market Analysis in US$ Million by End-Use: 2012-2019
    • TABLE 186: Radiopharmaceuticals Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 187: Rest of Asia-Pacific Market for Radiopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 188: Radiopharmaceuticals Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 189: Rest of Asia-Pacific Radiopharmaceuticals Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 190: Rest of Asia-Pacific Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 191: Rest of Asia-Pacific Radiopharmaceuticals Market in US$ Million by Application: 2012-2019
    • TABLE 192: Radiopharmaceuticals Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027
    • TABLE 193: Rest of Asia-Pacific Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 194: Rest of Asia-Pacific Radiopharmaceuticals Market in US$ Million by End-Use: 2012-2019
    • TABLE 195: Radiopharmaceuticals Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 196: Latin American Radiopharmaceuticals Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 197: Radiopharmaceuticals Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 198: Latin American Radiopharmaceuticals Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 199: Latin American Radiopharmaceuticals Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 200: Radiopharmaceuticals Historic Market Analysis in Latin America in US$ Million by Product Type: 2012-2019
    • TABLE 201: Latin American Radiopharmaceuticals Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 202: Latin American Demand for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 203: Radiopharmaceuticals Market Review in Latin America in US$ Million by Application: 2012-2019
    • TABLE 204: Latin American Radiopharmaceuticals Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 205: Latin American Demand for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 206: Radiopharmaceuticals Market Review in Latin America in US$ Million by End-Use: 2012-2019
    • TABLE 207: Latin American Radiopharmaceuticals Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • ARGENTINA
    • TABLE 208: Argentinean Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 209: Radiopharmaceuticals Market in Argentina in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 210: Argentinean Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 211: Argentinean Radiopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 212: Radiopharmaceuticals Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 213: Argentinean Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 214: Argentinean Radiopharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 215: Radiopharmaceuticals Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 216: Argentinean Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 217: Radiopharmaceuticals Market in Brazil by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 218: Brazilian Radiopharmaceuticals Historic Market Scenario in US$ Million by Product Type: 2012-2019
    • TABLE 219: Brazilian Radiopharmaceuticals Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 220: Radiopharmaceuticals Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027
    • TABLE 221: Brazilian Radiopharmaceuticals Historic Market Review in US$ Million by Application: 2012-2019
    • TABLE 222: Brazilian Radiopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 223: Radiopharmaceuticals Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2020-2027
    • TABLE 224: Brazilian Radiopharmaceuticals Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 225: Brazilian Radiopharmaceuticals Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • MEXICO
    • TABLE 226: Radiopharmaceuticals Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 227: Mexican Radiopharmaceuticals Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 228: Mexican Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 229: Radiopharmaceuticals Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 230: Mexican Radiopharmaceuticals Market in Retrospect in US$ Million by Application: 2012-2019
    • TABLE 231: Radiopharmaceuticals Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027
    • TABLE 232: Radiopharmaceuticals Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 233: Mexican Radiopharmaceuticals Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 234: Radiopharmaceuticals Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 235: Rest of Latin America Radiopharmaceuticals Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 236: Radiopharmaceuticals Market in Rest of Latin America by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 237: Rest of Latin America Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 238: Rest of Latin America Radiopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 239: Radiopharmaceuticals Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019
    • TABLE 240: Radiopharmaceuticals Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027
    • TABLE 241: Rest of Latin America Radiopharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 242: Radiopharmaceuticals Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2012-2019
    • TABLE 243: Radiopharmaceuticals Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 244: The Middle East Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 245: Radiopharmaceuticals Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 246: The Middle East Radiopharmaceuticals Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 247: The Middle East Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
    • TABLE 248: The Middle East Radiopharmaceuticals Historic Market by Product Type in US$ Million: 2012-2019
    • TABLE 249: Radiopharmaceuticals Market in the Middle East: Percentage Share Breakdown of Sales by Product Type for 2012,2020, and 2027
    • TABLE 250: The Middle East Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 251: Radiopharmaceuticals Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 252: The Middle East Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 253: The Middle East Radiopharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 254: Radiopharmaceuticals Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 255: The Middle East Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • IRAN
    • TABLE 256: Iranian Market for Radiopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
    • TABLE 257: Radiopharmaceuticals Market in Iran: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
    • TABLE 258: Iranian Radiopharmaceuticals Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
    • TABLE 259: Iranian Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 260: Iranian Radiopharmaceuticals Market in US$ Million by Application: 2012-2019
    • TABLE 261: Radiopharmaceuticals Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027
    • TABLE 262: Iranian Demand Estimates and Forecasts for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 263: Iranian Radiopharmaceuticals Market in US$ Million by End-Use: 2012-2019
    • TABLE 264: Radiopharmaceuticals Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 265: Israeli Radiopharmaceuticals Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
    • TABLE 266: Radiopharmaceuticals Market in Israel in US$ Million by Product Type: A Historic Review for the Period 2012-2019
    • TABLE 267: Israeli Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 268: Israeli Radiopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 269: Radiopharmaceuticals Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 270: Israeli Radiopharmaceuticals Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 271: Israeli Radiopharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 272: Radiopharmaceuticals Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 273: Israeli Radiopharmaceuticals Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 274: Saudi Arabian Radiopharmaceuticals Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
    • TABLE 275: Radiopharmaceuticals Historic Market Analysis in Saudi Arabia in US$ Million by Product Type: 2012-2019
    • TABLE 276: Saudi Arabian Radiopharmaceuticals Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 277: Saudi Arabian Demand for Radiopharmaceuticals in US$ Million by Application: 2020 to 2027
    • TABLE 278: Radiopharmaceuticals Market Review in Saudi Arabia in US$ Million by Application: 2012-2019
    • TABLE 279: Saudi Arabian Radiopharmaceuticals Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 280: Saudi Arabian Demand for Radiopharmaceuticals in US$ Million by End-Use: 2020 to 2027
    • TABLE 281: Radiopharmaceuticals Market Review in Saudi Arabia in US$ Million by End-Use: 2012-2019
    • TABLE 282: Saudi Arabian Radiopharmaceuticals Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED ARAB EMIRATES
    • TABLE 283: Radiopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 284: United Arab Emirates Radiopharmaceuticals Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 285: Radiopharmaceuticals Market Share Distribution in United Arab Emirates by Product Type: 2012 VS 2020 VS 2027
    • TABLE 286: Radiopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
    • TABLE 287: United Arab Emirates Radiopharmaceuticals Historic Market Analysis in US$ Million by Application: 2012-2019
    • TABLE 288: Radiopharmaceuticals Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027
    • TABLE 289: Radiopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
    • TABLE 290: United Arab Emirates Radiopharmaceuticals Historic Market Analysis in US$ Million by End-Use: 2012-2019
    • TABLE 291: Radiopharmaceuticals Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 292: Radiopharmaceuticals Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
    • TABLE 293: Rest of Middle East Radiopharmaceuticals Historic Market Analysis in US$ Million by Product Type: 2012-2019
    • TABLE 294: Rest of Middle East Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 295: Radiopharmaceuticals Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 296: Rest of Middle East Radiopharmaceuticals Market in Retrospect in US$ Million by Application: 2012-2019
    • TABLE 297: Radiopharmaceuticals Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027
    • TABLE 298: Radiopharmaceuticals Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 299: Rest of Middle East Radiopharmaceuticals Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 300: Radiopharmaceuticals Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 301: African Radiopharmaceuticals Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
    • TABLE 302: Radiopharmaceuticals Market in Africa by Product Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 303: African Radiopharmaceuticals Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
    • TABLE 304: African Radiopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 305: Radiopharmaceuticals Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019
    • TABLE 306: Radiopharmaceuticals Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027
    • TABLE 307: African Radiopharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 308: Radiopharmaceuticals Historic Demand Patterns in Africa by End-Use in US$ Million for 2012-2019
    • TABLE 309: Radiopharmaceuticals Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 61